Abivax S.A.

NASDAQ: ABVX · Real-Time Price · USD
77.23
2.80 (3.76%)
At close: Aug 22, 2025, 1:09 PM

Abivax S.A. Cash Flow Statement

Financials in EUR. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-176.24M -147.74M -60.74M -42.56M
Depreciation & Amortization
1.1M 707K 485K 156K
Stock-Based Compensation
20.22M 8.18M -1.16M 828K
Other Working Capital
276K 3.74M 74K n/a
Other Non-Cash Items
-577K 9.65M 9.48M -1.84M
Deferred Income Tax
n/a 7.93M n/a -828K
Change in Working Capital
1.42M 21.27M -2M -668K
Operating Cash Flow
-154.07M -100.01M -53.94M -45.66M
Capital Expenditures
-643K -265K -323K -1.64M
Cash Acquisitions
n/a n/a -2.91M 312K
Purchase of Investments
n/a -9.35M -470K -126K
Sales Maturities Of Investments
n/a 741K 218K -312K
Other Investing Acitivies
16.4M -1.62M -8.57M 312K
Investing Cash Flow
15.76M -10.49M -12.03M -1.46M
Debt Repayment
37.49M 15.24M -9.71M 19.13M
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
-9.71M -28.06M -4.45M -10.3M
Financial Cash Flow
28.21M 340.57M 32.21M 78.51M
Net Cash Flow
-107.72M 224.99M -33.75M 31.4M
Free Cash Flow
-154.72M -100.28M -54.26M -47.3M